Bioer has announced that its BSJ01 HPV Genotyping Real-Time PCR Kit (fluorescent PCR) has obtained CE-IVDR registration, which the company presents as a milestone for its women’s health molecular diagnostics.
Bioer reports clinical performance figures of 99.84% sensitivity, 99.27% specificity and 99.67% accuracy for the kit.
Source: Bioer (LinkedIn)
Date: 26 August 2026
Original: https://www.linkedin.com/posts/bioer-global_activity-7498175721861922816-bWY2